Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Nicholas Swart"'
Autor:
Robbie Foy, Fabiana Lorencatto, Rebecca Walwyn, Amanda Farrin, Jill Francis, Natalie Gould, Stephen McIntyre, Riya Patel, James Smith, Camilla During, Suzanne Hartley, Robert Cicero, Liz Glidewell, John Grant-Casey, Megan Rowley, Alison Deary, Nicholas Swart, Stephen Morris, Michelle Collinson, Lauren Moreau, Jon Bird, Susan Michie, Jeremy M Grimshaw, Simon J Stanworth
Publikováno v:
Programme Grants for Applied Research, Vol 10, Iss 2 (2022)
Background: Blood transfusion is a common but costly treatment. Repeated national audits in the UK suggest that up to one-fifth of transfusions are unnecessary when judged against recommendations for good clinical practice. Audit and feedback seeks t
Externí odkaz:
https://doaj.org/article/05f8606470924391be28b62b0e5aabd8
Autor:
Nicholas Swart, Roberta Maroni, Beth Muldrew, Peter Sasieni, Rebecca C. Fitzgerald, Stephen Morris
Publikováno v:
EClinicalMedicine, Vol 37, Iss , Pp 100969- (2021)
Background: Esophageal adenocarcinoma has a very poor prognosis unless detected early. The Cytosponge-trefoil factor 3 (TFF3) is a non-endoscopic test for Barrett esophagus, a precursor of esophageal adenocarcinoma. Randomised controlled trial data f
Externí odkaz:
https://doaj.org/article/2aac5b043da6416a9ef4075b7e95a72a
Autor:
Wendy Atkin, Amanda J Cross, Ines Kralj-Hans, Eilidh MacRae, Carolyn Piggott, Sheena Pearson, Kate Wooldrage, Jeremy Brown, Fiona Lucas, Aaron Prendergast, Natalie Marchevsky, Bhavita Patel, Kevin Pack, Rosemary Howe, Hanna Skrobanski, Robert Kerrison, Nicholas Swart, Julia Snowball, Stephen W Duffy, Stephen Morris, Christian von Wagner, Stephen Halloran
Publikováno v:
Health Technology Assessment, Vol 23, Iss 1 (2019)
Background: In the UK, patients with one or two adenomas, of which at least one is ≥ 10 mm in size, or three or four small adenomas, are deemed to be at intermediate risk of colorectal cancer (CRC) and referred for surveillance colonoscopy 3 years
Externí odkaz:
https://doaj.org/article/cb3398fda28b4cb3915ca8d980f85aee
Autor:
Timothy S Walsh, Simon Stanworth, Julia Boyd, David Hope, Sue Hemmatapour, Helen Burrows, Helen Campbell, Elena Pizzo, Nicholas Swart, Stephen Morris
Publikováno v:
Health Technology Assessment, Vol 21, Iss 62 (2017)
Background: At present, red blood cells (RBCs) are stored for up to 42 days prior to transfusion. The relative effectiveness and safety of different RBC storage times prior to transfusion is uncertain. Objective: To assess the clinical effectiveness
Externí odkaz:
https://doaj.org/article/0c8a177e800d43458692b4321f7ef4c6
Autor:
Stephen Morris, Peter Sasieni, Rebecca C. Fitzgerald, Beth Muldrew, Nicholas Swart, Roberta Maroni
Publikováno v:
EClinicalMedicine
EClinicalMedicine, Vol 37, Iss, Pp 100969-(2021)
EClinicalMedicine, Vol 37, Iss, Pp 100969-(2021)
BackgroundEsophageal adenocarcinoma has a very poor prognosis unless detected early. The Cytosponge-trefoil factor 3 (TFF3) is a non-endoscopic test for Barrett esophagus, a precursor of esophageal adenocarcinoma. Randomised controlled trial data fro
Autor:
Beth Muldrew, Rebecca C. Fitzgerald, Stephen Morris, Nicholas Swart, Roberta Maroni, Peter Sasieni
Publikováno v:
SSRN Electronic Journal.
Background: Oesophageal adenocarcinoma (EAC) has a very poor prognosis unless detected early. The Cytosponge-trefoil factor 3 (TFF3) is a non-endoscopic test for Barrett’s oesophagus, a precursor of EAC. Randomised controlled trial data from the BE
Autor:
Helen Campbell, Sue Hemmatapour, David Hope, Timothy S. Walsh, Nicholas Swart, Julia Boyd, Helen Burrows, Elena Pizzo, Stephen Morris, Simon J. Stanworth
Publikováno v:
Health Technology Assessment, Vol 21, Iss 62 (2017)
2017, ' The Age of Blood Evaluation randomised controlled trial (ABLE) : Description of the UK funded arm of the international trial, the UK cost-utility analysis, and secondary analyses exploring factors associated with health-related quality of life and healthcare costs during 12 month follow-up ', Health Technology Assessment, vol. 21, no. 62 . https://doi.org/10.3310/hta21620
2017, ' The Age of Blood Evaluation randomised controlled trial (ABLE) : Description of the UK funded arm of the international trial, the UK cost-utility analysis, and secondary analyses exploring factors associated with health-related quality of life and healthcare costs during 12 month follow-up ', Health Technology Assessment, vol. 21, no. 62 . https://doi.org/10.3310/hta21620
BackgroundAt present, red blood cells (RBCs) are stored for up to 42 days prior to transfusion. The relative effectiveness and safety of different RBC storage times prior to transfusion is uncertain.ObjectiveTo assess the clinical effectiveness and c
Publikováno v:
Vox sanguinisReferences. 115(4)
BACKGROUND AND OBJECTIVES Responding to national and local pressures to reduce the amount of blood transfused, the haematology department of Oxford University Hospitals (OUH), UK implemented an electronic blood-ordering system with clinical decision
Autor:
Amanda J, Cross, Kate, Wooldrage, Emma C, Robbins, Ines, Kralj-Hans, Eilidh, MacRae, Carolyn, Piggott, Iain, Stenson, Aaron, Prendergast, Bhavita, Patel, Kevin, Pack, Rosemary, Howe, Nicholas, Swart, Julia, Snowball, Stephen W, Duffy, Stephen, Morris, Christian, von Wagner, Stephen P, Halloran, Wendy S, Atkin
Publikováno v:
Gut. 68(9)
The English Bowel Cancer Screening Programme (BCSP) recommends 3 yearly colonoscopy surveillance for patients at intermediate risk of colorectal cancer (CRC) postpolypectomy (those with three to four small adenomas or one ≥10 mm). We investigated w
Autor:
Bhavita Patel, Robert S Kerrison, Stephen P Halloran, Wendy Atkin, Stephen Morris, Rosemary Howe, Aaron Prendergast, Christian von Wagner, Jeremy P Brown, Kevin Pack, S Pearson, Natalie Marchevsky, Kate Wooldrage, Hanna Skrobanski, Nicholas Swart, Ines Kralj-Hans, Julia Snowball, Eilidh MacRae, Stephen W. Duffy, Fiona Lucas, Carolyn Piggott, Amanda J. Cross
Publikováno v:
Health Technology Assessment, Vol 23, Iss 1 (2019)
Background In the UK, patients with one or two adenomas, of which at least one is ≥ 10 mm in size, or three or four small adenomas, are deemed to be at intermediate risk of colorectal cancer (CRC) and referred for surveillance colonoscopy 3 years p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28a7c9e5b0615c0fdf288d3e4a431e66
http://hdl.handle.net/10044/1/65961
http://hdl.handle.net/10044/1/65961